Tag: Heart / Stroke-Related: High Cholesterol
Migraine Frequency, Intensity Linked to Cholesterol Levels
Number and intensity of crises reduced in association with reduction in total, LDL cholesterol
Gut Microbiome May Play Role in BMI, HDL Cholesterol Levels
But more research needed to understand how different bacteria affect risk factors for heart disease
ICER: New Cholesterol Drugs Highly Overpriced
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
FDA Approves Repatha for Certain Patients With High Cholesterol
Approved for patients unable to get LDL cholesterol under control with current treatment options
Metabolic Changes With Metformin May Lower LDL-C
Possible metabolic mechanism includes activation of AMPK, FADS suppression
Calculated LDL-C Varies at Lower Values of Measured LDL-C
For calculated LDL-C of 30 mg/dL, 95 percent confidence interval was 24 to 60 mg/dL
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
New Guidelines Deemed Better for Identifying Statin Candidates
New guidelines would have 13 million more Americans taking the cholesterol drugs, experts say
VA/DoD Release Guidelines for Dyslipidemia Management
Key features include elimination of treatment targets, additional testing only when rationale clear
FDA Panel Recommends Approval of Second PCSK9 Inhibitor
Evolocumab (Repatha) for use in patients at very high risk for high cholesterol
